drugset / Trial / NCT01755169

Ketamine in Chronic Kid's (KiCK) Pain

NCT01755169 ↗

Phase 2 Terminated 7 enrolled Medical University of South Carolina
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to select the most tolerable dose of oral ketamine for children with chronic pain. Children will be given either placebo or one of three dosages of oral ketamine for 2 weeks. The dosage that is most tolerable will be selected for further study.

Timeline

Start
2013-01
Primary completion
2015-05
Completion
2015-05

Outcome

Outcome not reported

Stopped (Enrollment): “Inability to enroll sufficient patients”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.25 mg/kg Oral
Subject Ketamine Small molecule 0.5 mg/kg Oral
Subject Ketamine Small molecule 1 mg/kg Oral

Indications